BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

BACKGROUND: Mutations in BRCA1 and BRCA2 are associated with better survival in ovarian cancer (OC) patients due to a better response to platinum-based chemotherapy. However, the impact of the BRCA1/2 mRNA-expression is not well characterized in OC. PATIENTS AND METHODS: We investigated BRCA1/2 mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Lax, Sigurd F., Marth, Christian, Fiegl, Heidelinde, Zeimet, Alain G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173779/
https://www.ncbi.nlm.nih.gov/pubmed/30111871
http://dx.doi.org/10.1038/s41416-018-0217-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173779/
https://www.ncbi.nlm.nih.gov/pubmed/30111871
http://dx.doi.org/10.1038/s41416-018-0217-4

Ejemplares similares